基于运动的心脏康复对患有慢性心力衰竭的患者在透气管大动脉置换后的心脏康复的影响:一项随机对照试验
Jingjin Song1, Xiang Chen, Bin Wang
1Author Affiliation: Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China (Song, Chen, Wang, Cheng, and Wang).
Journal of cardiopulmonary rehabilitation and prevention
|November 27, 2024
概括
基于运动的个性化心脏康复 (CR) 显著改善了慢性心力衰竭 (HF) 患者的心肺功能和运动耐受性,这些患者在经过透气管大动脉置换 (TAVR) 后进行了透气管大动脉置换. 在运动训练组中,生活质量也有所改善.
科学领域:
- 心脏病学 心脏病学
- 心血管康复心血管康复
- 运动生理学 运动生理学
背景情况:
- 慢性心力衰竭 (HF) 带来了重大挑战,特别是透气管后的大动脉置换 (TAVR).
- 在HF患者中,在TAVR后优化恢复和功能能力对于长期结果至关重要.
- 个性化的运动干预措施可以提高康复的有效性.
研究的目的:
- 为了评估基于运动的心脏康复 (CR) 的影响,与个性化的运动处方.
- 为了评估其对慢性心力衰竭 (HF) 患者的影响,经过过导管大动脉置换 (TAVR).
- 在随机对照试验中,比较运动训练 (ET) 组和对照组之间的结果.
主要方法:
- 60名患有TAVR后慢性HF的患者随机分为控制 (传统康复) 和ET (基于心肺运动测试 (CPX) 的个性化CR) 组.
- 干预持续了12周,评估包括CPX参数,心声学,6分钟步行测试 (6MWT) 和生活质量 (明尼苏达州心力衰竭问卷).
- 进行症状限制CPX以指导运动处方和评估安全性.
主要成果:
- 与对照组相比,ET组在厌氧值,氧气吸收峰值,氧气脉冲峰值,峰值功率和左心室喷射率显著改善 (P < .05).
- 在ET组与对照组 (P < .05) 中,观察到6分钟步行测试距离的显著增加.
- ET组在明尼苏达州心力衰竭生活问卷上报告得分明显较低,表明生活质量有所改善 (P < .05).
结论:
- 以运动为基础的CR与个性化的运动处方有效改善慢性HF患者的心肺功能TAVR后.
- 这种方法提高了运动耐受性,并大大提高了这些患者的生活质量.
- 个性化CR代表了HF患者接受TAVR的有价值的治疗策略.
相关概念视频
01:20Exercise and Cardiovascular Response
737
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
737
01:17Aortic Regurgitation IV: Nursing Management
12
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
12
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:17Exercise and Cardiac Output
923
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
923
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K